Numerous ASX resources stocks delivered gains despite a tough market cycle. Here's a collection of the top winners and ...

Bulk commodities again defied the odds, with iron ore and coal prices remaining solid in 2024 This year’s fastest rising iron ...

In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.

Miners alarmed at requirement to sign native title agreements with increasing royalty payments to groups asserting ...

ASX falls after Wall Street sell-off, with Nvidia, Microsoft sliding and Bitcoin tumbling as traders take profits.

Workplace Relations Minister Murray Watt says Australians do not want “robots making arbitrary decisions about workers’ ...

Felix Gold has laid its antimony ambitions bare, targeting 2025 restart of historic Scrafford mine in Alaska after this ...

Gold benefits from central bank buying and rate cuts, while copper shows long-term promise, with a broker backing both for ...

ASX 200 drops as Santa rally fades, but energy, gold and Brainchip shine while Apollo's Slok backs US economy.

Dimerix (ASX:DXB) secured orphan drug designation for the treatment in the US and Europe, opening the door to a faster ...

Telix CEO Chris Behrenbruch has been awarded a 68% base pay rise ahead of expected FDA approval of its kidney cancer ...

The gas market in 2024 offered both challenges and opportunities, here are the companies that threaded the needle and ...